Journal Mobile Options
Table of Contents
Vol. 35, No. 2-3, 2002
Issue release date: March–June 2002
Psychopathology 2002;35:139–144

Neuroscience, Genetics, and the Future of Psychiatric Diagnosis

Hyman S.E.
Harvard University, Cambridge, Mass., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Nearly three decades after Robins and Guze’s seminal delineation of the steps required to validate a psychiatric diagnosis, a pathophysiologically based classification of psychiatric disorders remains elusive. Contrary to optimistic expectations, approaches to diagnostic validity based on clinical description, laboratory studies, natural history of illness, and familial aggregation have not converged to yield a nosology based on valid disease entities. Defining a rational nosology for disorders of the brain, the body’s most complex organ, is clearly one of the great challenges for modern medical science. Nonetheless, fundamental advances in our understanding of the genetic and environmental determinants of disease risk, and of the neural circuitry supporting normal and pathological mental processes promises to form the basis of improved classification in the coming decades.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 3 (DSM-III). Washington, American Psychiatric Association, 1980.
  2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4 (DSM-IV). Washington, American Psychiatric Association, 1994.
  3. World Health Organization: Mental Disorders: Glossary and Guide to their Classification in Accordance with the Ninth Revision of the International Classification of Diseases (ICD-9). Geneva, World Health Organization, 1978.
  4. World Health Organization: The ICD-10 Classification of Mental and Behavioural Disorders. Geneva, World Health Organization, 1992.
  5. McKusick VA: Mendelian Inheritance in Man. Catalogs of Human Genes and Genetic Disorders. Baltimore, Johns Hopkins University Press, 1998. (
  6. Venter JC, Adams MD, Myers EW, et al: The sequence of the human genome. Science 2001;291:1304–1351.
  7. The Genome International Sequencing Consortium: Initial sequencing and analysis of the human genome. Nature 2001;409:860–921.
  8. National Institute of Mental Health Genetics Workgroup: Genetics and Mental Disorders. Bethesda, NIH Publication No 98–4268, 1998. (
  9. Armour JAL, Anttinen T, May CA, Vega EE, Sajantila A, Kidd JR, Kidd KK, Bertranpetit J, Paabo S, Jeffreys AJ: Minisatellite diversity supports a recent African origin for modern humans. Nat Genet 1996;13:154–160.

    External Resources

  10. Robins E, Guze SB: Establishment of diagnostic validity in psychiatric illness: Its application to schizophrenia. Am J Psychiatry 1970;126:983–987.
  11. Hettema JM, Neale MC, Kendler, KS: A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 2001;158:1568–1578.
  12. Berrettini WH: Are schizophrenic and bipolar disorders related? A review of family and molecular studies. Biol Psychiatry 2002;48:531–538.
  13. Kendell RE: The Role of Diagnosis in Psychiatry. London, Blackwell, 1975.
  14. Cooper JE, Kendell RE, Gurland BJ, Sharpe L, Copeland JRM, Simon R: Psychiatric diagnosis in New York and London: A comparative study of hospital admissions. New York, Oxford University Press, 1972.
  15. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 3 Revised (DSM-III-R). Washington, American Psychiatric Association, 1987.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50